logo

For the Inventor, By the Inventor

Murray Hill, NJ, United States of America

Richard W Burg

This inventor holds 7 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1982-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard W Burg. Retrieved from https://idiyas.com/inventor/richard-w-burg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 191(Granted Patents)


Location History:

  • New Providence, NJ (US) (1989)
  • Murray Hill, NJ (US) (1982 - 1992)

Company Filing History:

goldMedal7 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1982-1992

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5130445 - Antifungal substances and process for their production (1992-07-14),
2. 5028537 - Novel antifungal substances and process for their production (1991-07-02),
3. 4871727 - Anti-inflammatory and antidegenerative compounds isolated from L-681,512 (1989-10-03),
4. 4814324 - Sterol inhibitors of testosterone 5.alpha.-reductase (1989-03-21),
5. 4575500 - Antifungal substances and process for their production (1986-03-11),
6. 4429042 - Strain of Streptomyces for producing antiparasitic compounds (1984-01-31),
7. 4310519 - Novel substances and process for their production (1982-01-12),

Title: **The Innovative Contributions of Richard W. Burg**

Introduction

Richard W. Burg is an accomplished inventor located in Murray Hill, NJ, USA. With a portfolio of seven patents, Burg has made significant strides in the field of antifungal research. His work focuses on the development of novel compounds with valuable properties that could impact various industries, particularly pharmaceuticals.

Latest Patents

Burg's latest patents revolve around the discovery of antifungal substances derived from the fermentation broth of a microorganism identified as MA-5000, which has been confirmed as a strain of *Streptomyces hygroscopicus*. His innovative work includes a series of macrolides, whose structures have been meticulously analyzed and documented. These compounds demonstrate notable antifungal activity, providing exciting opportunities for the development of new treatments against fungal infections.

Career Highlights

Richard W. Burg is associated with Merck & Company, Inc., a renowned global healthcare company known for its innovative contributions to medicine and pharmaceutical development. His role at Merck allows him to leverage his expertise in microbiology and pharmacology to bring cutting-edge solutions to market.

Collaboration

Throughout his career, Burg has worked alongside esteemed colleagues, including Otto D. Hensens and Sebastian Hernandez. These collaborations have further enriched his research endeavors, leading to shared advancements in the field of antifungal substances and their applications.

Conclusion

Richard W. Burg stands out as a pivotal figure in antifungal research, with a commendable array of patents that underscore his innovative spirit and commitment to scientific progress. His work at Merck & Company, Inc. continues to inspire advancements in healthcare, highlighting the importance of collaboration and research in tackling pressing medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…